{
  "pmcid": "3254747",
  "sha256": "388d0bf121742daf10f56f0703a77fc58c14c9f3764de3184f70913223d2b97a",
  "timestamp_utc": "2025-11-09T23:47:52.427701+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.978194867333624,
    "reading_ease": 39.040163114397586,
    "word_count": 242
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Polyhexamethylene Biguanide-Impregnated Gauze for Reducing Pin Site Infection in External Fixation"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to the PHMB group (22 limbs) or the control group (18 limbs)."
      },
      "Participants": {
        "score": 2,
        "evidence": "38 patients (40 limbs) undergoing limb lengthening or deformity correction with external fixators were enrolled at a single center"
      },
      "Intervention": {
        "score": 2,
        "evidence": "PHMB-impregnated gauze is more effective than plain gauze"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates whether polyhexamethylene biguanide (PHMB)-impregnated gauze is more effective than plain gauze in reducing pin tract infections."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the rate of pin tract infection, evaluated at 2, 4, 8, and 12 weeks post-surgery"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "The outcome assessor was blinded to the type of gauze used."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants were randomly assigned to the PHMB group (22 limbs) or the control group (18 limbs)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The infection rate was significantly lower in the PHMB group (1.0%) compared to the control group (4.5%), with a relative risk of 0.228 (95% CI, 0.118 to 0.443; p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not disclosed."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}